Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Go back to Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
(NASDAQ: EPRX) Delayed: 6.68 -0.68 (9.24%)
Previous Close $7.36    52 Week High
Open $7.38    52 Week Low
Day High $7.45    P/E N/A 
Day Low $6.67    EPS
Volume 174,229